Terms: = Kidney tumors AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Clinical Outcome
3 results:
1. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
[TBL] [Abstract] [Full Text] [Related]
2. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients.
Andersen MB; Ebbesen D; Thygesen J; Kruis M; Rasmussen F
Eur Radiol; 2020 Oct; 30(10):5539-5550. PubMed ID: 32367416
[TBL] [Abstract] [Full Text] [Related]
3. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
